State healthcare spending benchmarks alone show limited impact on costs, highlighting need for stronger enforcement, complementary pricing policies, and better data to effectively control hospital prices and premiums.

IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.

New cholesterol guidelines emphasize earlier screening, personalized risk assessment, and aggressive LDL reduction, incorporating genetic factors like lipoprotein(a) to improve prevention, while raising cost, access, and overdiagnosis concerns.

Psilocybin-assisted therapy shows promise for treatment-resistant mental disorders, but widespread adoption depends on resolving safety, training, regulatory, and access challenges while ensuring durable, equitable patient outcomes.

Medicare Shared Savings Program shows net savings over a decade, but results vary, highlighting benefits of value-based care alongside concerns about costs, equity, and program design.

Ketamine-assisted psychotherapy combined with mindfulness-based MORE shows promise for opioid use disorder by reducing cravings and improving regulation, but raises safety, training, and access challenges.

Catheter-based aspiration offers a less invasive option for right-sided infective endocarditis, enabling vegetation removal and infection control in high-risk patients while requiring careful selection and multidisciplinary management.

AI-enhanced 3D body scans improve metabolic syndrome risk detection beyond BMI by capturing fat distribution, enabling earlier, personalized interventions while raising challenges in cost, access, and algorithm fairness.

In metastatic colorectal cancer, late-line therapy choices balance survival, toxicity, and convenience; SUNLIGHT data suggest neutropenia may signal effective drug exposure, guiding individualized treatment and supportive care decisions.

THP regimen matches TCbHP in pCR for HER2-positive early breast cancer, while reducing toxicity, supporting de-escalation strategies that preserve efficacy, improve tolerability, and streamline care delivery.